Clinical Trial

A Study of HDM2006 in Patients With Advanced Solid Tumor

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a first-in-human (FIH) study to evaluate the safety and preliminary efficacy of experimental drug HDM2006 in patients with advanced solid tumors.
Trial Details
NCT Number NCT07377591
Lead Sponsor Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions Advanced Solid Tumors
Enrollment 48 participants
Start Date 2024-12-31
Primary Completion 2026-09 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-30